NR4A1 and breast carcinoma: The peaks in breast cancer death in different hormone receptor states all occurred over 2 years but the risk of breast cancer death in hormone receptor-positive disease was significantly higher than that of single or both hormone receptor-negative disease (12% vs. 5–7%).